# FDA Inspection 1047799 - Dermatology Consulting Services - March 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/dermatology-consulting-services/798b4bd1-9f10-4f36-a59a-8bafd86b4643
Source feed: FDA_Inspections

> FDA Inspection 1047799 for Dermatology Consulting Services on March 29, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1047799
- Company Name: Dermatology Consulting Services
- Inspection Date: 2018-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 724023 - 2011-05-05](https://www.keypedia.com/records/fda_inspections/dermatology-consulting-services/a2108034-6eab-4316-befb-fb97de4162aa)
- [FDA Inspection 584573 - 2009-05-22](https://www.keypedia.com/records/fda_inspections/dermatology-consulting-services/13bc7530-b359-4521-a86f-61466341e52e)

Company: https://www.keypedia.com/companies/dermatology-consulting-services/71e00324-7bfd-4c60-964d-5862ddb9746b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c